Show simple item record

dc.contributor.authorGUMUS, F
dc.contributor.authorMihmanli, I
dc.contributor.authorKaya, Güner
dc.contributor.authorKantarci, Fatih
dc.contributor.authorKaynak, K
dc.contributor.authorAltintas, F
dc.contributor.authorCansever, Mehmet Şerif
dc.date.accessioned2021-03-05T17:53:37Z
dc.date.available2021-03-05T17:53:37Z
dc.date.issued2005
dc.identifier.citationAltintas F., GUMUS F., Kaya G., Mihmanli I., Kantarci F., Kaynak K., Cansever M. Ş. , "Interscalene brachial plexus block with bupivacaine and ropivacaine in patients with chronic renal failure: Diaphragmatic excursion and pulmonary function changes", ANESTHESIA AND ANALGESIA, cilt.100, ss.1166-1171, 2005
dc.identifier.issn0003-2999
dc.identifier.othervv_1032021
dc.identifier.otherav_c7bdafc5-b350-4d8e-b9ac-1c2f5e769400
dc.identifier.urihttp://hdl.handle.net/20.500.12627/132380
dc.identifier.urihttps://doi.org/10.1213/01.ane.0000154443.68396.70
dc.description.abstractIn this randomized, double-blind study, we compared the anesthetic characteristics and pulmonary function changes of 0.33% bupivacaine and 0.33% ropivacaine used for interscalene brachial plexus (IBP) anesthesia in patients with chronic renal failure. Forty-two patients undergoing IBP anesthesia for creation of arteriovenous fistulas were randomly allocated to receive either 30 mL of 0.33% bupivacaine (Group B) or 0.33% ropivacaine (Group R). Block onset time, diaphragmatic excursion (ultrasonographic evaluation), and free plasma concentrations of bupivacaine and ropivacaine were evaluated. Negative motion or immobility of the ipsilateral hemidiaphragm and a decrease of > 10 mm in positive motion were defined as diaphragmatic paresis. The pulmonary function variables were measured by bedside spirometry equipment. Seven patients needed supplemental local anesthetic, one with total spinal block; these patients were excluded from the study. The success rate was 80.9%. Block quality was similar in the two groups. Ipsilateral hemidiaphragmatic excursion was decreased in both groups compared with baseline values (P 0.05). Pulmonary function significantly decreased from baseline in both groups (forced vital capacity (FVC) 30%, forced expiratory volume at 1 second (FEV1) 32%, and peak expiratory flow (PEF) 31% in Group B and FVC 17%, FEV1 17%, and PEF 5% in Group R) (P 0.05). Concentrations of bupivacaine and ropivacaine were below toxic levels rather than "normal range." We conclude that pulmonary function decreased more after IBP with 0.33% bupivacaine than with 0.33% ropivacaine.
dc.language.isoeng
dc.subjectCerrahi Tıp Bilimleri
dc.subjectSağlık Bilimleri
dc.subjectAnesteziyoloji
dc.subjectKlinik Tıp (MED)
dc.subjectTıp
dc.subjectANESTEZİYOLOJİ
dc.subjectKlinik Tıp
dc.titleInterscalene brachial plexus block with bupivacaine and ropivacaine in patients with chronic renal failure: Diaphragmatic excursion and pulmonary function changes
dc.typeMakale
dc.relation.journalANESTHESIA AND ANALGESIA
dc.contributor.department, ,
dc.identifier.volume100
dc.identifier.issue4
dc.identifier.startpage1166
dc.identifier.endpage1171
dc.contributor.firstauthorID1317


Files in this item

FilesSizeFormatView

There are no files associated with this item.

This item appears in the following Collection(s)

Show simple item record